Renal natriuretic effects of atrial natriuretic peptide in dogs with alloxan-induced acute pulmonary edema.
OBJECTIVE
To test the effect of atrial natriuretic peptide (ANF) in dogs with acute pulmonary edema in the absence of urinary sodium retention. ANF is normally a potent natriuretic agent, although this effect is attenuated in generalized edema or acute renal failure.


METHODS
Animal study.


METHODS
Twenty-nine dogs.


METHODS
Induction of acute pulmonary edema with intravenously administered alloxan and administration of ANF according to five protocols.


METHODS
Natriuretic effect of ANF before and after the induction of pulmonary edema during the protocols.


RESULTS
In six control animals, induction of pulmonary edema was associated with diuresis (mean 0.38, standard error of the mean [SEM] 0.003 mL/min before alloxan administration v. mean 0.75, SEM 0.11 mL/min after); natriuresis (mean 60, SEM 8 mumol/min before v. mean 103, SEM 12 mumol/min after); and a decline in blood pressure (mean 114, SEM 7 mm Hg before v. mean 93, SEM 9 mm Hg after) and in the glomerular filtration rate (mean 52, SEM 3.3 mL/min before v. mean 36, SEM 3.7 mL/min after). When isoncotic dextran solution was infused in dogs with pulmonary edema, blood pressure was maintained but the glomerular filtration rate still declined by 42% and there was natriuresis. When the renal arteries were clamped for 5 minutes during the infusion of alloxan, diuresis and natriuresis were prevented, but the glomerular filtration rate still declined, although blood pressure was maintained. ANF administered intravenously during pulmonary edema induced a further significant natriuresis in all experimental protocols. Catalase, administered intravenously as a bolus just before the alloxan infusion, prevented pulmonary edema and the associated renal changes.


CONCLUSIONS
Although alloxan appears to be directly nephrotoxic, renal damage caused by this compound does not impair the natriuretic effect of ANF in acute pulmonary edema.
Levy
M
M
Department of Physiology, McGill University, Montreal, Que.
Cernacek
P
P
D000208:Acute Disease; D000496:Alloxan; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D002374:Catalase / Q000494:pharmacology; D004231:Diuresis; D004285:Dogs; D005260:Female; D005919:Glomerular Filtration Rate; D007668:Kidney / Q000503:physiopathology*; D008297:Male; D009318:Natriuresis; D011654:Pulmonary Edema / Q000139:chemically induced / Q000503:physiopathology*
D000496:Alloxan; D009320:Atrial Natriuretic Factor; D002374:Catalase